✨ Ask AkshayaAI anything about this stock — instant AI answers. Try the AI assistant →
AkshayaAIStocks › HCA

HCA — HCA Healthcare Inc

AI Signal & Stock Analysis · Weak ↓

As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for HCA is Weak ↓; the stock is at $406.07 (-1.38% today); neutral (RSI 53); technical trend is down-trend; news sentiment is positive.

Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.

Key metrics

AI signal (Strength)Weak ↓
Price$406.07
Change today-1.38%
RSI (14)52.81
Relative volume0.39
Composite (RMTPGV) score🔒 members
Market cap$87.9B
Forward P/E12.60
52-week high-27.1% away
52-week low+14.7% above
Technical trendDown-trend (since 2024-01-26)
News sentimentPositive
SectorHealthcare-Services
Next earnings7/24/2026 8:30:00 AM

What's driving the signal

🔒 AkshayaAI factor scores — Momentum, Technical, Performance, Growth, Volatility and the composite RMTPGV score are members-only. Sign in free to see the full breakdown →
Ask a follow-up or get live data on HCA → open the AI assistant

Frequently asked about HCA

What is AkshayaAI's signal for HCA today?

As of Aug 14 2026, 1:04 PM, AkshayaAI assigns HCA (HCA Healthcare Inc) a Weak signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.

Is HCA overbought or oversold right now?

HCA's RSI is neutral (RSI 53). A reading above 70 is typically considered overbought and below 30 oversold.

Where is HCA in its 52-week range?

HCA is trading about 27% below its 52-week high and 15% above its 52-week low as of Aug 14 2026, 1:04 PM.

When is HCA's next earnings date?

HCA's next earnings date is 7/24/2026 8:30:00 AM.

What sector is HCA in?

HCA is classified under Healthcare-Services in AkshayaAI's taxonomy.

AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.

🤖

Ask AkshayaAI about HCA

Instant, data-backed answers — free to try.